Ratings Concentrix Corporation

Equities

CNXC

US20602D1019

Real-time Estimate Cboe BZX Other stock markets 01:15:46 2024-05-02 pm EDT			5-day change	1st Jan Change
56.23 ^USD	+1.68%		+1.29%	-42.78%

Mar. 28	North American Morning Briefing : Stocks Set for -2-	DJ
Mar. 27	BofA Securities Downgrades Concentrix to Underperform From Neutral	MT

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

The company's attractive earnings multiples are brought to light by a P/E ratio at 11.46 for the current year.
With regards to fundamentals, the enterprise value to sales ratio is at 0.89 for the current period. Therefore, the company is undervalued.
The company has a low valuation given the cash flows generated by its activity.
Over the last twelve months, the sales forecast has been frequently revised upwards.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses

The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The company does not generate enough profits, which is an alarming weak point.
The group shows a rather high level of debt in proportion to its EBITDA.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last few months, analysts have been revising downwards their earnings forecast.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Business Support Services

	1st Jan change	Capi.	ESG Refinitiv
CONCENTRIX CORPORATION	-43.69%	3.65B	B-
CINTAS CORPORATION	+10.11%	67.33B	B+
JACOBS SOLUTIONS INC.	+10.32%	17.99B	B+
BUREAU VERITAS SA	+19.72%	13.29B	A-
RB GLOBAL, INC.	+6.70%	13.04B	B-
INTERTEK GROUP PLC	+16.53%	9.85B	B-
TELEPERFORMANCE SE	-27.86%	5.54B	C
GENPACT LIMITED	-11.50%	5.54B	A-
MAXIMUS, INC.	-3.72%	4.93B	B-
EXLSERVICE HOLDINGS, INC.	-5.77%	4.72B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes